OFT refers Alliance acquisition to competition regulator

By
LaingBuisson
-

Alliance Medical’s acquisition of IBA Molecular has today been referred to the Competition Commission by the Office of Fair Trading (OFT).

You must be a HM Subscriber to view this content.

Subscribe Now »

RELATED ARTICLESMORE FROM AUTHOR